Analyst Research

Report Title Price
Provider: Finlabo SIM Spa
$10.00
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA Reaches USD 40 Million Settlement in U.S. Lawsuit-Reuters


Thursday, 19 Sep 2013 06:44pm EDT 

Reuters reported that Sanofi SA has reached a USD 40 million settlement of a U.S. lawsuit accusing the Company of misleading investors about the safety of a weight loss pill that a U.S. regulatory panel linked to suicidal thoughts. The all-cash settlement was disclosed in a court filing on September 19, 2013 and requires approval by U.S. District Judge. It resolves claims that arose after a U.S. Food and Drug Administration advisory committee on June 13, 2007 urged that the agency reject the Company's drug rimonabant, known by the trade names Acomplia and Zimulti, on concern that using it could increase suicidal thinking and depression. 

Company Quote

76.54
0.73 +0.96%
5:13am EDT